Reportergen-mRNA Deutschland

• 

  Reporter Gene mRNA as a Tool for Studying Gene Expression

  Reporter gene mRNA helps scientists determine when and where in the body a gene is being used, same with Yaohai's Zulassungsfragen für Biologika. For example, they may examine how a particular gene is used by different cells in the body. This information is useful because it helps biologists understand how lighting up that gene fits into the overall function of the body. Scientists can use these insights to figure out how different genes work together to keep our bodies healthy.

• 

  A Promising Strategy for Disease Treatment

  Reporter gene mRNA may also be useful in curing selected illnesses, along with the Hefefermentation zur VLP-Produktion made by Yaohai. It could help scientists deliver the right treatments directly to the sick cells themselves. The approach is beneficial as it helps scientists in pinpointing the problem area. Once the treatment reached the diseased cells, they can turn back to the reporter gene mRNA to switch on the therapeutic.

• 

  Advancements in Reporter Gene mRNA Technology

  The most notable of these new advances is the use of nanoparticles — minuscule particles used to carry the mRNA into cells, as well as the Yaohai's Hochertragreiche Plasmidfermentation. Nanoparticles are very tiny, and can be engineered specially to carry medicines or other therapies. And they can be engineered to go after particular cells in the body. This will allow scientists to confirm the treatment only makes it to where it is supposed to go.

Why choose Yaohai Reporter Gene mRNA?

• Qualitätssystem und Einhaltung globaler Vorschriften

  Reporter Gene mRNA is a Top 10 Microbial CDMO that incorporates quality control and regulatory matters. We have established a robust quality system that complies with the current GMP standards and regulations all over the world. Our regulatory team is well-versed on global regulatory frameworks to speed up biological launches. We guarantee traceable production processes and top-quality products that are compliant with the rules of US FDA, EU EMA, Australia TGA, and China NMPA. Yaohai BioPharma successfully passed an audit on site conducted by an accredited Qualified Person from the European Union (QP) to review our GMP system and production facility. Additionally, we've passed the first certification audits of the ISO9001 Quality Management System, ISO14001 Environmental Management System, and ISO45001 Occupational Health and Safety Management System.

• Fachkompetenz und langjährige Erfahrung

  Yaohai Bio-Pharma is a leading in microbial biologics CDMO. Our primary focus is the production of microbial vaccinations and therapeutics for managing pets, human and Reporter Gene mRNA. We are equipped with cutting-edge RD platforms as well as manufacturing technologies that encompass the entire process beginning with the development of microbial strains and cell banking, to method and process development, to clinical and commercial manufacture that ensures the successful supply of new solutions. Through the years, we have accumulated vast knowledge of microbial-based bio processing. Over 200 projects have been successfully completed and we assist our clients to get through regulations, such as those of the US FDA and EU EMA. We also assist them in navigating Australia TGA and China NMPA. We are able respond promptly to market demands and offer tailored CDMO services thanks to our experience and expertise.

• Robuste Lieferkette und Fertigungskapazitäten

  Yaohai Bio-Pharma is a Top 10 biological company that specializes in Reporter Gene mRNA. We have built a modern manufacturing facility with robust RD capabilities and modern manufacturing facilities. Five drug substance production lines complying with GMP standards for microbial fermentation and purification along with two fill and final lines for vials and cartridges as well as pre-filled needles are readily available. The available fermentation scales vary between 100L and 2000L. The filling volume ranges from 1ml up to 25ml. Syringes or cartridges that are pre-filled are filled with 3 to 3.5ml. Our production workshop that is cGMP-compliant ensures constant supply of clinical sample and commercial products. Our facility produces large molecules that are exported to all over the world.

• Anpassung, Effizienz und Kosteneffizienz

  Reporter Gene mRNA has experience in manufacturing biologics that are that are derived from microorganisms. We provide tailored RD as well as manufacturing solutions, while minimising the risk. We have experimented with a variety of techniques, such as recombinant cellular subunits of vaccines (including peptides), growth factors, hormones and the cytokines. We have specialized in multiple microorganisms like yeast extracellular and intracellular secretion (yields up to 15g/L) and bacteria intracellular soluble and inclusion bodies (yields up to 10g/L). We also have the BSL-2 fermentation platform to develop bacterial vaccines. We are experts in improving processes, increasing product yields, and decreasing production costs. With an effective technology team, we ensure timely and quality project delivery and bring your products to market faster.

Verwandte Produktkategorien

• AAV-Plasmidherstellung
• Analytische Methoden für Plasmid-DNA
• Herstellung des Bakteriophagen AP205 VLP
• Herstellung von Bakteriophage Q VLP
• Herstellung chimärer VLP-Impfstoffe
• Herstellung konjugierter VLP-Impfstoffe
• Herstellung von DNA-Impfstoffen
• E. coli-Fermentation zur VLP-Produktion
• Herstellung von GLP-1-Agonisten
• GLP-1 Analoge Fertigung

Finden Sie nicht, was Sie suchen?
Kontaktieren Sie unsere Berater für weitere verfügbare Produkte.